Related Experiment Video
Updated: May 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to
Divya Rana1, Nazha Abughali, Deepak Kumar
1Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH 44109, USA.
Objective:
To determine epidemiology and clinical characteristics of infants with methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA) in a level III neonatal intensive care unit (NICU).
Study Design:
All NICU admissions (2001 to 2008) with any positive S. aureus culture were included as cases. Cases were further characterized as either colonized or infected with invasive disease.
Results:
Four thousand three hundred four infants were admitted; 273 (6.3%) had at least one culture positive for S. aureus, including 198 with MSSA and 75 with MRSA. Invasive disease occurred in 23.2% of MSSA cases versus 29.3% MRSA (p = 0.298). Between the study periods 2001 to 2005 versus 2006 to 2008, the incidence of all MSSA cultures (colonization and invasive disease) decreased from 53.6 to 38.9/1000 admissions (p = 0.044), and that of MRSA increased from 13.7 to 24.77/1000 admissions (p = 0.010). The incidence of invasive MSSA (p = 0.49) and MRSA (p = 0.38) disease between the two periods remained similar. Infants with invasive MRSA versus MSSA had a longer duration of positive cultures (55 versus 19 days, p = 0.009). None of five available isolates collected prior to 2006 was characterized as USA300, but 11/21 isolates collected subsequently were USA300 (p = 0.053).
Conclusion:
The incidence of MRSA (colonization and infection) nearly doubled during the study period coinciding with emergence of community-acquired MRSA USA300.
Insights
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) nearly doubled in neonatal intensive care units, coinciding with the emergence of the community-acquired MRSA USA300 strain. Methicillin-susceptible S. aureus (MSSA) rates declined during the same period.
Area of Science:
- Neonatal Intensive Care Unit (NICU) epidemiology
- Infectious disease surveillance
- Bacterial resistance patterns
Background:
- Staphylococcus aureus is a common cause of neonatal infections.
- Distinguishing between methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains is crucial for treatment and understanding epidemiology.
- Neonatal intensive care units are vulnerable settings for healthcare-associated infections.
Purpose of the Study:
- To investigate the epidemiology and clinical features of S. aureus infections in a level III NICU.
- To compare outcomes and trends of MSSA versus MRSA in neonates.
- To identify factors associated with MRSA emergence in the NICU.
Main Methods:
- Retrospective cohort study of all NICU admissions from 2001 to 2008.
- Inclusion of all infants with positive S. aureus cultures.
- Classification of cases as colonized, infected, or with invasive disease.
Main Results:
- S. aureus was identified in 6.3% of admitted infants (273/4304), with 198 MSSA and 75 MRSA cases.
- The incidence of MRSA cultures (colonization and invasive disease) increased significantly from 13.7 to 24.77 per 1000 admissions between 2001-2005 and 2006-2008 (p=0.010).
- Conversely, MSSA culture incidence decreased (p=0.044). Invasive disease rates remained similar for both MSSA and MRSA.
- Infants with invasive MRSA had a longer duration of positive cultures (55 vs. 19 days, p=0.009).
- The USA300 strain, associated with community-acquired MRSA, emerged during the later study period.
Conclusions:
- MRSA colonization and infection nearly doubled during the study period.
- The rise in MRSA coincided with the emergence of the community-acquired MRSA USA300 strain.
- These findings highlight the changing landscape of S. aureus epidemiology in NICUs.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
